REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 159 filers reported holding REATA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,120,000 | +260.3% | 20,000 | +233.3% | 2.00% | +146.9% |
| Q1 2020 | $866,000 | -89.0% | 6,000 | -84.5% | 0.81% | -84.9% |
| Q4 2019 | $7,890,000 | +158.6% | 38,600 | +1.6% | 5.36% | +128.8% |
| Q3 2019 | $3,051,000 | -5.9% | 38,000 | +10.6% | 2.34% | +5.0% |
| Q2 2019 | $3,241,000 | +18.5% | 34,350 | +7.3% | 2.23% | +14.1% |
| Q1 2019 | $2,735,000 | +52.4% | 32,000 | 0.0% | 1.96% | +22.5% |
| Q4 2018 | $1,795,000 | -31.4% | 32,000 | 0.0% | 1.60% | -6.7% |
| Q3 2018 | $2,616,000 | +87.0% | 32,000 | -20.0% | 1.71% | +72.7% |
| Q2 2018 | $1,399,000 | – | 40,000 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |